
HLS Therapeutics
Provides access to treatments critical to patients and their caregivers with the brand names they trust.
Market cap
$123m
Enterprise value
$167m
Share price
CAD5.35 HLS.TO
Authorizing premium user...
Provides access to treatments critical to patients and their caregivers with the brand names they trust.